Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 million.
Baxter ups IV fluid allocations amid supply shortages
Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Baxter said Wednesday it would increase allocation